Karen L. MacKenzie

4.7k citations

68 papers · 2.4k indexed · h-index 29

Molecular Biology top 5%
Oncology top 5%
Hematology top 2%
Physiology top 5%
Cancer Research top 10%

Co-authors: Malcolm A.S. Moore Richard B. Lock Greg M. Arndt Kacper Jankowski Michel Sadelain Murray D. Norris George A. Wolff Michelle Haber
Topics: Telomeres, Telomerase, and Senescence (17 papers)Acute Myeloid Leukemia Research (15 papers)Acute Lymphoblastic Leukemia research (8 papers)
Cited by: Hematology Genetics Aging
Journals: Nucleic Acids Research Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: Australia United States United Kingdom

In The Last Decade

Karen L. MacKenzie

68 papers receiving 2.4k citations

Peers

Countries citing papers authored by Karen L. MacKenzie

Since Specialization

Citations

This map shows the geographic impact of Karen L. MacKenzie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen L. MacKenzie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen L. MacKenzie more than expected).

Fields of papers citing papers by Karen L. MacKenzie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen L. MacKenzie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen L. MacKenzie. The network helps show where Karen L. MacKenzie may publish in the future.

Co-authorship network of co-authors of Karen L. MacKenzie

This figure shows the co-authorship network connecting the top 25 collaborators of Karen L. MacKenzie. A scholar is included among the top collaborators of Karen L. MacKenzie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen L. MacKenzie. Karen L. MacKenzie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma 2020 ·British Journal of Cancer ·(unknown),(unknown),Andrew J. Gifford,Carol Wadham,(unknown),Emily Mould,Mitali Fadia,Lei Zhai,Hassina Massudi,(unknown),Glenn M. Marshall,Robyn Lukeis,Jamie I. Fletcher,Karen L. MacKenzie,Toby N. Trahair	21
2	DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts 2019 ·Haematologica ·(unknown),(unknown),Kathy Knezevic,Julie A.I. Thoms,Georg von Jonquières,Christine E. Napier,(unknown),(unknown),(unknown),Michelle F. Maritz,Hilda A. Pickett,Jonathan Morris,John E. Pimanda,Karen L. MacKenzie	22
3	Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 2017 ·BMC Genomics ·Susan Corley,Karen L. MacKenzie,Annemiek Beverdam,Louise F. Roddam,Marc R. Wilkins	27
4	MYC -Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of Dyskerin 2016 ·Cancer Research ·(unknown),Sieu L. Tran,Michelle F. Maritz,Bing Liu,Cheng Kong,Stefania Purgato,Chen Yang,Jayne Murray,Amanda J. Russell,Claudia L. Flemming,Georg von Jonquières,Hilda A. Pickett,Wendy B. London,Michelle Haber,Preethi H. Gunaratne,Murray D. Norris,Giovanni Perini,Jamie I. Fletcher,Karen L. MacKenzie	36
5	A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of anERG-driven transcriptional network 2016 ·Nucleic Acids Research ·Ashwin Unnikrishnan,Yi Fang Guan,Yizhou Huang,Dominik Beck,Julie A.I. Thoms,Sofie Peirs,Kathy Knezevic,Shiyong Ma,Inge Van de Walle,(unknown),(unknown),Ling Zhong,Mark J. Raftery,Tom Taghon,Jonas Larsson,Karen L. MacKenzie,Pieter Van Vlierberghe,Jason W.H. Wong,John E. Pimanda	16
6	Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study 2016 ·EBioMedicine ·Eddy Pasquier,Nicolás André,Janine Street,Anuradha Chougule,Bharat Rekhi,Jaya Ghosh,(unknown),(unknown),Karen L. MacKenzie,Maria Kavallaris,Shripad Banavali	86
7	Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 2014 ·Leukemia ·Melinda L. Tursky,Dominik Beck,Julie A.I. Thoms,Yizhou Huang,(unknown),Ashwin Unnikrishnan,Kathy Knezevic,Kathryn Evans,(unknown),(unknown),Jonathan Morris,Lior Goldberg,Shai Izraeli,Jason W.H. Wong,Jake Olivier,Richard B. Lock,Karen L. MacKenzie,John E. Pimanda	17
8	Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells 2012 ·Angiogenesis ·Eddy Pasquier,(unknown),Janine Street,(unknown),Karen L. MacKenzie,Diane Braguer,Nicolás André,Maria Kavallaris	47
9	Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16INK4a during immortalization 2012 ·Oncogene ·(unknown),(unknown),Eddy Pasquier,Kacper Jankowski,Melissa H. Chang,(unknown),Maria Kavallaris,Karen L. MacKenzie	11
10	Induction of Vascular Endothelial Growth Factor Secretion by Childhood Acute Lymphoblastic Leukemia Cells via the FLT-3 Signaling Pathway 2011 ·Molecular Cancer Therapeutics ·Ana Marković,Karen L. MacKenzie,Richard B. Lock	12
11	Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells 2010 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Christine E. Napier,(unknown),(unknown),Lisa Taylor,Jun Yuan,(unknown),Alexander C. James,Tracey O’Brien,Richard B. Lock,Karen L. MacKenzie	16
12	Inactivation of Myocardin and p16 during Malignant Transformation Contributes to a Differentiation Defect 2007 ·Cancer Cell ·Michael Milyavsky,Igor Shats,(unknown),Ran Brosh,Yosef Buganim,Lilach Weisz,Ira Kogan,Merav Cohen,Maria Shatz,Shalom Madar,Eyal Kalo,Naomi Goldfinger,Jun Yuan,(unknown),Karen L. MacKenzie,Amir Eden,Varda Rotter	61
13	Over-expression of p53 mutants in LNCaP cells alters tumor growth and angiogenesis in vivo 2006 ·Biochemical and Biophysical Research Communications ·Lara Perryman,Julie M. Blair,Elizabeth A. Kingsley,Bożena Szymańska,Kim Ow,(unknown),Karen L. MacKenzie,Peter Vermeulen,P. Jackson,Pamela J. Russell	12
14	Osteopetrotic Mouse Stroma with Thrombopoietin, c-kit Ligand, and flk-2 Ligand Supports Long-Term Mobilized CD34 ⁺ Hematopoiesis In Vitro 2005 ·Stem Cells and Development ·Pierre Feugier,Na Li,Deog‐Yeon Jo,(unknown),Karen L. MacKenzie,Jean‐François Lesesve,Véronique Latger‐Cannard,Danièle Bensoussan,Ronald G. Crystal,Shahin Rafii,(unknown),Malcolm A.S. Moore	20
15	FLT-3: a new focus in the understanding of acute leukemia 2005 ·The International Journal of Biochemistry & Cell Biology ·Ana Marković,Karen L. MacKenzie,Richard B. Lock	51
16	Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse 2004 ·Experimental Hematology ·Sylvie Shen,Alla Dolnikov,Toby Passioura,Michelle Millington,Simon Wotherspoon,Alison Rice,Karen L. MacKenzie,Geoff Symonds	23
17	Ex vivo Expansion of Stem and Progenitor Cells in Co-culture of Mobilized Peripheral Blood CD34 ⁺ Cells on Human Endothelium Transfected with Adenovectors Expressing Thrombopoietin, c-kit Ligand, and Flt-3 Ligand 2002 ·Journal of Hematotherapy & Stem Cell Research ·Pierre Feugier,Deog Yeon Jo,(unknown),Karen L. MacKenzie,Shahin Rafii,Ronald G. Crystal,Malcolm A.S. Moore	21
18	Methotrexate selection of long-term culture initiating cells following transduction of CD34+ cells with a retrovirus containing a mutated human dihydrofolate reductase gene 2002 ·Cancer Gene Therapy ·Naoko Takebe,Licheng Xu,Karen L. MacKenzie,Joseph R. Bertino,Malcolm A.S. Moore	9
19	Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras 2002 ·Oncogene ·Karen L. MacKenzie,Sonia Franco,Afzal J. Naiyer,Chad May,Michel Sadelain,Shahin Rafii,Malcolm A.S. Moore	56
20	Optimizing Conditions for Gene Transfer into Human Hematopoietic Cells 1999 ·PubMed ·Malcolm A.S. Moore,Karen L. MacKenzie	5

About Karen L. MacKenzie

Karen L. MacKenzie is a scholar working on Aging, Hematology and Oncology, having authored 68 papers that have together received 2.4k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (17 papers), Acute Myeloid Leukemia Research (15 papers) and Acute Lymphoblastic Leukemia research (8 papers). The work is most often cited by research in Hematology (528 citations), Genetics (231 citations) and Aging (37 citations). Karen L. MacKenzie has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Malcolm A.S. Moore, Richard B. Lock, Greg M. Arndt, Kacper Jankowski, Michel Sadelain, Murray D. Norris, George A. Wolff, Michelle Haber, Chad May and Jörg Cammenga. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact